Advancing the potential of peptide-PMO compounds in exon skipping therapy for DMD

Benzer Materyaller

• Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.
  Yazar:: Betts, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
  Yazar:: Betts, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
  Yazar:: Blain, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
  Yazar:: Alison M Blain, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-01-01)
• Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts.
  Yazar:: Joshua Lee, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-01-01)